Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
TCI Co., Ltd. Becomes Asia's First Biotechnology Company Whose Climate Ambitions Are Validated by SBTi
TCI Co., Ltd. (8436. TWO), the leading nutraceutical ODM company, announced on April 22nd that it is […]
Guy's and St Thomas' NHS Foundation Trust Selects Nuance Dragon Medical One As Part of a Large-Scale Digital Transformation
Nuance Communications, Inc. (NASDAQ: NUAN) today announced that Guy’s and St Thomas’ NHS Foundation Trust (the Trust) chose Nuance Dragon […]
Allergan to Share New Data at ARVO 2021
Allergan, an AbbVie (NYSE: ABBV) company, today announced that it will present new data, including […]
WHO Supports Greece in Building a National Health System for the 21st Century
During his visit to Greece last week, WHO’s Regional Director for Europe, Dr Hans Henri […]
Veritas Intercontinental Opens Its Advanced Genomics Laboratory in Europe
Veritas Intercontinental has recently opened its next generation genomics laboratory specialized in Whole Exome and Whole Genome […]
Cannabics Pharmaceuticals Launches a New Research Program to Develop a Melanoma Treatment Drug Candidate for FDA Approval Track
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, […]
Samsung Biologics and TG Therapeutics Expand Collaboration for the Large Scale Manufacture of Ublituximab
Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization and TG Therapeutics […]
Jolly Good/Teijin Pharma Develop VR Digital Therapeutics for Depression
Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality […]
Novo Holdings Participates in US$ 80 Million Series C Investment in Indonesia's Largest Health-tech Platform Halodoc
Novo Holdings today announced that it has joined the US$ 80 million Series C financing in Halodoc, […]
Peijia Medical TaurusOne® Approved for Commercialization
A new interventional solution from China for structural heart disease is about to be launched onto the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more